These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28302518)

  • 21. Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: A cohort study.
    Elkaim E; Neven B; Bruneau J; Mitsui-Sekinaka K; Stanislas A; Heurtier L; Lucas CL; Matthews H; Deau MC; Sharapova S; Curtis J; Reichenbach J; Glastre C; Parry DA; Arumugakani G; McDermott E; Kilic SS; Yamashita M; Moshous D; Lamrini H; Otremba B; Gennery A; Coulter T; Quinti I; Stephan JL; Lougaris V; Brodszki N; Barlogis V; Asano T; Galicier L; Boutboul D; Nonoyama S; Cant A; Imai K; Picard C; Nejentsev S; Molina TJ; Lenardo M; Savic S; Cavazzana M; Fischer A; Durandy A; Kracker S
    J Allergy Clin Immunol; 2016 Jul; 138(1):210-218.e9. PubMed ID: 27221134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The First Iranian Cohort of Pediatric Patients with Activated Phosphoinositide 3-Kinase-δ (PI3Kδ) Syndrome (APDS).
    Fekrvand S; Delavari S; Chavoshzadeh Z; Sherkat R; Mahdaviani SA; Sadeghi Shabestari M; Azizi G; Arzanian MT; Shahin Shamsian B; Eskandarzadeh S; Eslami N; Rae W; Condino-Neto A; Mohammadi J; Abolhassani H; Yazdani R; Aghamohammadi A
    Immunol Invest; 2022 Apr; 51(3):644-659. PubMed ID: 33401995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activated PI3Kδ syndrome type 2: Two patients, a novel mutation, and review of the literature.
    Olbrich P; Lorenz M; Cura Daball P; Lucena JM; Rensing-Ehl A; Sanchez B; Führer M; Camacho-Lovillo M; Melon M; Schwarz K; Neth O; Speckmann C
    Pediatr Allergy Immunol; 2016 Sep; 27(6):640-4. PubMed ID: 27116393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PIK3R1 Mutation Associated with Hyper IgM (APDS2 Syndrome): A Case Report and Review of the Literature.
    Yazdani R; Hamidi Z; Babaha F; Azizi G; Fekrvand S; Abolhassani H; Aghamohammadi A
    Endocr Metab Immune Disord Drug Targets; 2019; 19(7):941-958. PubMed ID: 30799802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short syndrome-an expanding phenotype.
    Singh A; Arora R; Singh P; Kapoor S
    Indian Pediatr; 2013 Apr; 50(4):414-6. PubMed ID: 23665600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced AKT Phosphorylation of Circulating B Cells in Patients With Activated PI3Kδ Syndrome.
    Asano T; Okada S; Tsumura M; Yeh TW; Mitsui-Sekinaka K; Tsujita Y; Ichinose Y; Shimada A; Hashimoto K; Wada T; Imai K; Ohara O; Morio T; Nonoyama S; Kobayashi M
    Front Immunol; 2018; 9():568. PubMed ID: 29675019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SHORT syndrome in a two-year-old girl - case report.
    Klatka M; Rysz I; Kozyra K; Polak A; Kołłątaj W
    Ital J Pediatr; 2017 May; 43(1):44. PubMed ID: 28472977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activated PI3 Kinase Delta Syndrome: From Genetics to Therapy.
    Michalovich D; Nejentsev S
    Front Immunol; 2018; 9():369. PubMed ID: 29535736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A New Homozygous IGF1R Variant Defines a Clinically Recognizable Incomplete Dominant form of SHORT Syndrome.
    Prontera P; Micale L; Verrotti A; Napolioni V; Stangoni G; Merla G
    Hum Mutat; 2015 Nov; 36(11):1043-7. PubMed ID: 26252249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BMP4 loss-of-function mutations in developmental eye disorders including SHORT syndrome.
    Reis LM; Tyler RC; Schilter KF; Abdul-Rahman O; Innis JW; Kozel BA; Schneider AS; Bardakjian TM; Lose EJ; Martin DM; Broeckel U; Semina EV
    Hum Genet; 2011 Oct; 130(4):495-504. PubMed ID: 21340693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variant PIK3R1 Hypermorphic Mutation and Clinical Phenotypes in a Family with Short Statures, Mild Immunodeficiency and Lymphoma.
    Hauck F; Magg T; Krolo A; Bilic I; Hirschmugl T; Laass M; Rösen-Wolff A; Luksch H; Boztug K; Roesler J
    Klin Padiatr; 2017 May; 229(3):113-117. PubMed ID: 28561224
    [No Abstract]   [Full Text] [Related]  

  • 32. Short telomere syndromes cause a primary T cell immunodeficiency.
    Wagner CL; Hanumanthu VS; Talbot CC; Abraham RS; Hamm D; Gable DL; Kanakry CG; Applegate CD; Siliciano J; Jackson JB; Desiderio S; Alder JK; Luznik L; Armanios M
    J Clin Invest; 2018 Dec; 128(12):5222-5234. PubMed ID: 30179220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systematic review of mortality and survival rates for APDS.
    Hanson J; Bonnen PE
    Clin Exp Med; 2024 Jan; 24(1):17. PubMed ID: 38280023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secondary C1q Deficiency in Activated PI3Kδ Syndrome Type 2.
    Hong Y; Nanthapisal S; Omoyinmi E; Olbrich P; Neth O; Speckmann C; Lucena JM; Gilmour K; Worth A; ; Klein N; Eleftheriou D; Brogan P
    Front Immunol; 2019; 10():2589. PubMed ID: 31781101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EXPANSION OF THE SHORT SYNDROME PHENOTYPE IN AN ADULT PATIENT WITH UNILATERAL BASAL GANGLIA CALCIFICATION.
    Salinas-Torres VM; De La O-Expinoza EA; Salinas-Torres RA
    Genet Couns; 2016; 27(4):479-483. PubMed ID: 30226966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful haploidentical hematopoietic stem cell transplantation for activated phosphoinositide 3-kinase δ syndrome: Case report and literature review.
    Yang X; Xi R; Bai J; Pan Y
    Medicine (Baltimore); 2023 Feb; 102(5):e32816. PubMed ID: 36749229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Respiratory Manifestations of the Activated Phosphoinositide 3-Kinase Delta Syndrome.
    Condliffe AM; Chandra A
    Front Immunol; 2018; 9():338. PubMed ID: 29556229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyper-activated PI3K-δ in immunodeficiency.
    Heurtier L; Deau MC; Kracker S
    Oncotarget; 2015 Jul; 6(21):18242-3. PubMed ID: 26286043
    [No Abstract]   [Full Text] [Related]  

  • 39. Extrahematopoietic manifestations of the short telomere syndromes.
    Schratz KE
    Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):115-122. PubMed ID: 33275732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A case of PIK3R1 gene variation induced SHORT syndrome].
    Cao BY; Wu D; Gong CX
    Zhonghua Er Ke Za Zhi; 2021 Mar; 59(3):228-230. PubMed ID: 33657699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.